Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2007-12-31 | Yoseph Shaaltiel, Ph.D. Dr. Shaaltiel founded Protalix Ltd. in 1993 and has served as a member of our Board of Directors and as our Vice President, Research and Development since December 31, 2006. |
| 2008-10-03 | Yoseph Shaaltiel, Ph.D. Dr. Shaaltiel founded Protalix Ltd. in 1993 and has served as a member of our Board of Directors and as our Vice President, Research and Development since December 31, 2006. Prior to establishing Protalix Ltd., from 1988 to 1993, Dr. Shaaltiel was a research associate at the MIGAL Technological Center. He also served as deputy head of the Biology Department of the Biological and Chemical Center of the Israeli Defense Forces and as a Biochemist at Makor Chemicals Ltd. Dr. Shaaltiel was a postdoctoral fellow at the University of California at Berkeley and at Rutgers University in New Jersey. He has co-authored over 40 articles and abstracts on plant biochemistry and holds seven patents. Dr. Shaaltiel received a Ph.D. in Plant Biochemistry from the Weizmann Institute of Science, an M.Sc. in Biochemistry from the Hebrew University and a B.Sc. in Biology from the Ben Gurion University. |
| 2009-09-18 | Yoseph Shaaltiel, Ph.D. Dr. Shaaltiel founded Protalix Ltd. in 1993 and has served as a member of our Board of Directors and as our Vice President, Research and Development since December 31, 2006. |
| 2010-10-04 | Yoseph Shaaltiel, Ph.D. Dr. Shaaltiel founded Protalix Ltd. in 1993 and has served as a member of our Board of Directors and as our Vice President, Research and Development since December 31, 2006. ... The following table sets forth a summary of the cash and non-cash compensation awarded, paid or accrued by us or Protalix Ltd. to each of our President and Chief Executive Officer, our Executive Vice President, Research and Development ... Yoseph Shaaltiel, Ph.D. 2009 196,271 160,000 225,336 37,981 619,588 |
| 2011-09-19 | Yoseph Shaaltiel, Ph.D. 58 Director and Executive VP, Research and Development ... Dr. Shaaltiel founded Protalix Ltd. in 1993 ... ... The following table sets forth information ... Name Age Position Yoseph Shaaltiel, Ph.D. 58 Director and Executive VP, Research and Development ... Compensation of Directors ... ... Dr. Shaaltiel entered into an employment agreement with Protalix Ltd. on September 1, 2001 ... ... Dr. Shaaltiel is entitled to be insured by Protalix Ltd. under a Manager's Policy in lieu of severance ... ... Dr. Shaaltiel is entitled to 24 working days of vacation. |
| 2013-09-20 | Yoseph Shaaltiel, Ph.D. 60 Director and Executive VP, Research and Development ...Dr. Shaaltiel founded Protalix Ltd. in 1993 and has served as a member of our Board of Directors and as our Vice President, Research and Development since December 31, 2006. |
| 2017-08-25 | The following table sets forth information, as of August 10, 2017, regarding beneficial ownership of our common stock: Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage of Class (%) Board of Directors and Executive Officers Yoseph Shaaltiel, Ph.D. |
| 2017-09-01 | Board of Directors and Executive Officers Yoseph Shaaltiel, Ph.D. Consists of 795,916 outstanding shares of our common stock and 630,603 shares of our common stock issuable upon exercise of outstanding options. |
| 2018-10-17 | Yoseph Shaaltiel, Ph.D.(7) |
| 2019-10-15 | Security Ownership of Certain Beneficial Owners and Management table |
Data sourced from SEC filings. Last updated: 2026-02-08